UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 905

Sortiert nach

SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma

Journal of clinical oncology, 2015-08, Vol.33 (24), p.2617-2622

2015

Link zum Volltext

Verfügbarkeit prüfen

Hepatocellular Carcinoma: Consensus Recommendations of the National Cancer Institute Clinical Trials Planning Meeting

Journal of clinical oncology, 2010-09, Vol.28 (25), p.3994-4005

2010

Link zum Volltext

Verfügbarkeit prüfen

Phase II Trial of the Combination of Bevacizumab and Erlotinib in Patients Who Have Advanced Hepatocellular Carcinoma

Journal of clinical oncology, 2009-02, Vol.27 (6), p.843-850

2009

Link zum Volltext

Verfügbarkeit prüfen

HER2/neu-directed therapy for biliary tract cancer

Journal of hematology and oncology, 2015-05, Vol.8 (1), p.58-58, Article 58

2015

Link zum Volltext

Verfügbarkeit prüfen

Vaccination with poly(IC:LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancer

Journal of hematology and oncology, 2017-04, Vol.10 (1), p.82-82, Article 82

2017

Link zum Volltext

Verfügbarkeit prüfen

A Randomized Phase II Open-Label Multi-Institution Study of the Combination of Bevacizumab and Erlotinib Compared to Sorafenib in the First-Line Treatment of Patients with Advanced Hepatocellular Carcinoma

Oncology, 2018-01, Vol.94 (6), p.329-339

2018

Link zum Volltext

Verfügbarkeit prüfen

Opportunities for Targeted Therapies in Hepatocellular Carcinoma

Journal of clinical oncology, 2005-11, Vol.23 (31), p.8093-8108

2005

Link zum Volltext

Verfügbarkeit prüfen

Antitumor effect of the novel sphingosine kinase 2 inhibitor ABC294640 is enhanced by inhibition of autophagy and by sorafenib in human cholangiocarcinoma cells

Oncotarget, 2016-04, Vol.7 (15), p.20080-20092

2016

Link zum Volltext

Verfügbarkeit prüfen

Phase 2 Trial of Induction Gemcitabine, Oxaliplatin, and Cetuximab Followed by Selective Capecitabine-Based Chemoradiation in Patients With Borderline Resectable or Unresectable Locally Advanced Pancreatic Cancer

International journal of radiation oncology, biology, physics, 2014-03, Vol.88 (4), p.837-844

2014

Link zum Volltext

Verfügbarkeit prüfen

Systemic Therapy for Hepatocellular Carcinoma: Cytotoxic Chemotherapy, Targeted Therapy and Immunotherapy

Annals of surgical oncology, 2008-04, Vol.15 (4), p.1008-1014

2008

Link zum Volltext

Verfügbarkeit prüfen

Biological characteristics of cancers in the gallbladder and biliary tract and targeted therapy

Critical reviews in oncology/hematology, 2007-01, Vol.61 (1), p.44-51

Thomas, Melanie B

2007

Link zum Volltext

Verfügbarkeit prüfen

A Phase I Study of ABC294640, a First-in-Class Sphingosine Kinase-2 Inhibitor, in Patients with Advanced Solid Tumors

Clinical cancer research, 2017-08, Vol.23 (16), p.4642-4650

2017

Link zum Volltext

Verfügbarkeit prüfen

Hepatocellular carcinoma: the need for progress

Journal of clinical oncology, 2005-05, Vol.23 (13), p.2892-2899

2005

Link zum Volltext

Verfügbarkeit prüfen

Phase 2 study of erlotinib in patients with unresectable hepatocellular carcinoma

Cancer, 2007-09, Vol.110 (5), p.1059-1067

2007

Link zum Volltext

Verfügbarkeit prüfen

Effect of metabolic syndrome and its components on recurrence and survival in colon cancer patients

Cancer, 2013-04, Vol.119 (8), p.1512-1520

2013

Link zum Volltext

Verfügbarkeit prüfen

Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin‐based chemotherapy for colorectal liver metastases

Cancer, 2007-12, Vol.110 (12), p.2761-2767

2007

Link zum Volltext

Verfügbarkeit prüfen

Interventional oncology: the fourth leg of the cancer treatment stool

Journal of the National Comprehensive Cancer Network, 2014-09, Vol.12 (9), p.1357

Thomas, Melanie B

2014

Link zum Volltext

Verfügbarkeit prüfen

Association between hypothyroidism and hepatocellular carcinoma: A case‐control study in the United States

Hepatology (Baltimore, Md.), 2009-05, Vol.49 (5), p.1563-1570

2009

Link zum Volltext

Verfügbarkeit prüfen

Systemic therapy for hepatocellular carcinoma

The cancer journal (Sudbury, Mass.), 2008-03, Vol.14 (2), p.123

Thomas, Melanie B

2008

Link zum Volltext

Verfügbarkeit prüfen

Racial disparities in advanced-stage colorectal cancer survival

Cancer causes & control, 2013-03, Vol.24 (3), p.463-471

2013

Link zum Volltext

Verfügbarkeit prüfen

Extrahepatic Bile Duct Adenocarcinoma: Patients at High-Risk for Local Recurrence Treated with Surgery and Adjuvant Chemoradiation Have an Equivalent Overall Survival to Patients with Standard-Risk Treated with Surgery Alone

Annals of surgical oncology, 2008-11, Vol.15 (11), p.3147-3156

2008

Link zum Volltext

Verfügbarkeit prüfen

Effect of different types of smoking and synergism with hepatitis C virus on risk of hepatocellular carcinoma in American men and women: Case‐control study

International journal of cancer, 2008-10, Vol.123 (8), p.1883-1891

2008

Link zum Volltext

Verfügbarkeit prüfen

The association of family history of liver cancer with hepatocellular carcinoma: A case-control study in the United States

Journal of hepatology, 2009-02, Vol.50 (2), p.334-341

2009

Link zum Volltext

Verfügbarkeit prüfen

Phase 1 study of TAS-102 administered once daily on a 5-day-per-week schedule in patients with solid tumors

Investigational new drugs, 2008-10, Vol.26 (5), p.445-454

2008

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Factors in Relation to Racial Disparity in Advanced Colorectal Cancer Survival

Clinical colorectal cancer, 2013-12, Vol.12 (4), p.287-293

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 905

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(865)
Mit Volltextzugriff
(793)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(692)
Life Sciences & Biomedicine
(572)
Humans
(476)
Female
(275)
Male
(242)
Middle Aged
(160)
Adult
(150)
Animals
(147)
Biological And Medical Sciences
(126)
Aged
(116)
Medical Sciences
(104)
Mice
(77)
Risk Factors
(73)
Oncology
(70)
Science & Technology - Other Topics
(69)
Multidisciplinary Sciences
(65)
Adolescent
(64)
Physical Sciences
(58)
Immunology
(56)
Genomes
(51)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma

Hepatocellular Carcinoma: Consensus Recommendations of the National Cancer Institute Clinical Trials Planning Meeting

Phase II Trial of the Combination of Bevacizumab and Erlotinib in Patients Who Have Advanced Hepatocellular Carcinoma

HER2/neu-directed therapy for biliary tract cancer

Vaccination with poly(IC:LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancer

A Randomized Phase II Open-Label Multi-Institution Study of the Combination of Bevacizumab and Erlotinib Compared to Sorafenib in the First-Line Treatment of Patients with Advanced Hepatocellular Carcinoma

Opportunities for Targeted Therapies in Hepatocellular Carcinoma

Antitumor effect of the novel sphingosine kinase 2 inhibitor ABC294640 is enhanced by inhibition of autophagy and by sorafenib in human cholangiocarcinoma cells

Phase 2 Trial of Induction Gemcitabine, Oxaliplatin, and Cetuximab Followed by Selective Capecitabine-Based Chemoradiation in Patients With Borderline Resectable or Unresectable Locally Advanced Pancreatic Cancer

Systemic Therapy for Hepatocellular Carcinoma: Cytotoxic Chemotherapy, Targeted Therapy and Immunotherapy

Biological characteristics of cancers in the gallbladder and biliary tract and targeted therapy

A Phase I Study of ABC294640, a First-in-Class Sphingosine Kinase-2 Inhibitor, in Patients with Advanced Solid Tumors

Hepatocellular carcinoma: the need for progress

Phase 2 study of erlotinib in patients with unresectable hepatocellular carcinoma

Effect of metabolic syndrome and its components on recurrence and survival in colon cancer patients

Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin‐based chemotherapy for colorectal liver metastases

Interventional oncology: the fourth leg of the cancer treatment stool

Association between hypothyroidism and hepatocellular carcinoma: A case‐control study in the United States

Systemic therapy for hepatocellular carcinoma

Racial disparities in advanced-stage colorectal cancer survival

Extrahepatic Bile Duct Adenocarcinoma: Patients at High-Risk for Local Recurrence Treated with Surgery and Adjuvant Chemoradiation Have an Equivalent Overall Survival to Patients with Standard-Risk Treated with Surgery Alone

Effect of different types of smoking and synergism with hepatitis C virus on risk of hepatocellular carcinoma in American men and women: Case‐control study

The association of family history of liver cancer with hepatocellular carcinoma: A case-control study in the United States

Phase 1 study of TAS-102 administered once daily on a 5-day-per-week schedule in patients with solid tumors

Prognostic Factors in Relation to Racial Disparity in Advanced Colorectal Cancer Survival

Suchergebnisse filtern